Related Experiment Video
Updated: May 3, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.3K
[Diabetes in general practice--were treatment goals reached?]
Summary
This study assessed adherence to diabetes clinical guidelines in a Norwegian general practice. While most guidelines were followed, achieving all treatment goals for HbA1c, blood pressure, and lipids presents an opportunity for improvement.
Area of Science:
- General Practice
- Diabetes Mellitus Management
- Clinical Guideline Adherence
Background:
- Most diabetes care in Norway is provided by general practitioners.
- This study evaluated a single general practice's adherence to the 2009 clinical guidelines for diabetes management.
Purpose of the Study:
- To assess the degree of adherence to the Norwegian Directorate of Health's 2009 clinical guidelines for diabetes treatment and management.
- To identify areas of success and potential improvement in diabetes care within a general practice setting.
Main Methods:
- Retrospective review of electronic health records for patients diagnosed with diabetes mellitus.
- Data collection focused on patient demographics, diagnostic tests (HbA1c, blood pressure, lipids), treatment goal achievement, and documented examinations between November 2009 and October 2010.
Main Results:
- 271 patients with diabetes (11% type 1, 88% type 2) were included.
- High rates of measurement for HbA1c (99%), blood pressure (98%), and LDL cholesterol (93%) were observed.
- Treatment goal achievement rates were 55% for HbA1c, 55% for systolic blood pressure, and 49% for LDL cholesterol, with 13% meeting all three goals.
Conclusions:
- The general practice largely follows most clinical guidelines for diabetes care.
- Achieved treatment goal rates align with previous Norwegian studies, indicating room for improvement.
- Further optimization of diabetes management strategies is possible within primary care settings.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26